A significantly higher percentage (33%) of early stage patients had a higher frequency (score 3 and 4) of combined PD-1 (PD-1 in the tumor epithelium and/or stroma) than those with advanced disease (17%) (P = 0.028, Table 6). Here, PDCD1 is linked to neoplasm.